Daniel Maria M.
- Country
- Austria
- Department
- Innere Medizin I
Research Overview
Data & Insights
Has run more than one trial at 0 of 100 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating follicular lymphoma, with particular focus on previously untreated cases exhibiting FLIPI 2-5 scores. Their research explores innovative therapeutic combinations for this specific lymphoma subtype.
- Advanced Lymphoma Management
- Novel Therapeutic Combinations
- First-line Treatment Strategies
Current interests include evaluating combination therapies incorporating monoclonal antibodies and targeted agents for lymphoma treatment.
Immunotherapy Research
The investigator focuses on advancing immunotherapeutic approaches in lymphoma treatment, particularly studying the application of anti-CD20 therapies and novel antibody combinations.
- Antibody-Based Therapies
- Immune System Modulation
- Treatment Response Assessment
Their work encompasses evaluation of immune-based interventions for improving patient outcomes in lymphoid malignancies.
Clinical Assessment
The investigator specializes in evaluating treatment efficacy through progression-free survival metrics and employs sophisticated assessment methodologies including Independent Review Committee evaluation protocols.
- Treatment Response Monitoring
- Prognostic Assessment
- Therapeutic Outcome Measurement
Their expertise includes implementing rigorous evaluation methods for therapeutic interventions in lymphoma treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.